scholarly journals Alpha-synuclein induces the unfolded protein response in Parkinson’s disease SNCA triplication iPSC-derived neurons

2017 ◽  
Vol 26 (22) ◽  
pp. 4441-4450 ◽  
Author(s):  
Sabrina M Heman-Ackah ◽  
Raquel Manzano ◽  
Jeroen JM Hoozemans ◽  
Wiep Scheper ◽  
Rowan Flynn ◽  
...  
2019 ◽  
Vol 111 (6) ◽  
pp. 161-168 ◽  
Author(s):  
Alexis Martinez ◽  
Nelida Lopez ◽  
Constanza Gonzalez ◽  
Claudio Hetz

2011 ◽  
Vol 116 (4) ◽  
pp. 588-605 ◽  
Author(s):  
Arianna Bellucci ◽  
Laura Navarria ◽  
Michela Zaltieri ◽  
Elisa Falarti ◽  
Serena Bodei ◽  
...  

2007 ◽  
Vol 354 (3) ◽  
pp. 707-711 ◽  
Author(s):  
J.J.M. Hoozemans ◽  
E.S. van Haastert ◽  
P. Eikelenboom ◽  
R.A.I. de Vos ◽  
J.M. Rozemuller ◽  
...  

Cells ◽  
2020 ◽  
Vol 9 (11) ◽  
pp. 2495
Author(s):  
Cristine Alves da Costa ◽  
Wejdane El Manaa ◽  
Eric Duplan ◽  
Frédéric Checler

Parkinson’s disease (PD) is a multifactorial age-related movement disorder in which defects of both mitochondria and the endoplasmic reticulum (ER) have been reported. The unfolded protein response (UPR) has emerged as a key cellular dysfunction associated with the etiology of the disease. The UPR involves a coordinated response initiated in the endoplasmic reticulum that grants the correct folding of proteins. This review gives insights on the ER and its functioning; the UPR signaling cascades; and the link between ER stress, UPR activation, and physiopathology of PD. Thus, post-mortem studies and data obtained by either in vitro and in vivo pharmacological approaches or by genetic modulation of PD causative genes are described. Further, we discuss the relevance and impact of the UPR to sporadic and genetic PD pathology.


Author(s):  
Andreia Carvalho ◽  
Catarina Ranito ◽  
Carolina Tavares ◽  
Margarida Castro-Caldas ◽  
Elsa Rodrigues ◽  
...  

2020 ◽  
Author(s):  
René L. Vidal ◽  
Denisse Sepulveda ◽  
Paulina Troncoso-Escudero ◽  
Paula Garcia-Huerta ◽  
Constanza Gonzalez ◽  
...  

AbstractAlteration to endoplasmic reticulum (ER) proteostasis is observed on a variety of neurodegenerative diseases associated with abnormal protein aggregation. Activation of the unfolded protein response (UPR) enables an adaptive reaction to recover ER proteostasis and cell function. The UPR is initiated by specialized stress sensors that engage gene expression programs through the concerted action of the transcription factors ATF4, ATF6f, and XBP1s. Although UPR signaling is generally studied as unique linear signaling branches, correlative evidence suggests that ATF6f and XBP1s may physically interact to regulate a subset of UPR-target genes. Here, we designed an ATF6f-XBP1s fusion protein termed UPRplus that behaves as a heterodimer in terms of its selective transcriptional activity. Cell-based studies demonstrated that UPRplus has stronger an effect in reducing the abnormal aggregation of mutant huntingtin and alpha-synuclein when compared to XBP1s or ATF6 alone. We developed a gene transfer approach to deliver UPRplus into the brain using adeno-associated viruses (AAVs) and demonstrated potent neuroprotection in vivo in preclinical models of Parkinson’s and Huntington’s disease. These results support the concept where directing UPR-mediated gene expression toward specific adaptive programs may serve as a possible strategy to optimize the beneficial effects of the pathway in different disease conditions.


Sign in / Sign up

Export Citation Format

Share Document